Syngoi
AcquiredWatertown, US · 2 known investors
Artis BioSolutions is an integrated platform for genetic medicine that produces enzymatically synthesized synthetic DNA and develops it into clinical-grade advanced therapies with in-house GMP manufacturing. It serves developers of advanced therapy medicinal products across modalities such as mRNA, gene editing, viral vectors, cell therapies, and vaccines, with production sites in Watertown, MA (US) and Bilbao, Spain (EU).
Investors · 2
Frequently asked questions
- What does Syngoi do?
- Artis BioSolutions is an integrated platform for genetic medicine that produces enzymatically synthesized synthetic DNA and develops it into clinical-grade advanced therapies with in-house GMP manufacturing. It serves developers of advanced therapy medicinal products across modalities such as mRNA, gene editing, viral vectors, cell therapies, and vaccines, with production sites in Watertown, MA (US) and Bilbao, Spain (EU).
- Who are Syngoi's investors?
- Syngoi's investors include Buenavista Equity Partners, Columbus Venture Partners.
- Where is Syngoi headquartered?
- Syngoi is headquartered in Watertown, US.